Stoke Therapeutics, Inc. has grown revenue 30% a year over three years and 146% a year over five. Revenue growth, 3-year annual rate: +30% (Biotechnology median +21%). Revenue growth, 5-year rate: +146%, growth has slowed since the five-year average. Years of annual history on file: 8, FY2018 to FY2025, as filed.

STOKStoke Therapeutics, Inc.

HealthcareUSD

$33.10

$13.1052 weeks$38.35

Is it growing?

Is STOK growing?

Stoke Therapeutics, Inc. has grown revenue 30% a year over three years and 146% a year over five.

+30%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +146%
Revenue growth, 5-year rate · +30% over three · growth has slowed since the five-year average
Years of annual history on file: 8
Years of annual history on file · FY2018 to FY2025, as filed

Details›